Drugs / YH14755
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02125227 | Apr → Sep 2014 | — | Yuhan Corporation | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02586129 | Nov 2015 → Jul 2017 | hyperlipidemia, type 2 diabetes mellitus | Yuhan Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YH14755 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02586129 ↗ |
| Route | Oral | “PO, Once Daily, 16 weeks” NCT02586129 ↗ |